ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report

Global and Region ICAD (Intracranial Atherosclerotic Disease) Pathology Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：216
  • REPORT CODE：GMM919325
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

    The report details the trend, potential and market size of ICAD (Intracranial Atherosclerotic Disease) Pathology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of ICAD (Intracranial Atherosclerotic Disease) Pathologymarket, defines the market attractiveness level of ICAD (Intracranial Atherosclerotic Disease) Pathology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of ICAD (Intracranial Atherosclerotic Disease) Pathology industry, describes the types of ICAD (Intracranial Atherosclerotic Disease) Pathology market, the applications of major players and the market size, and deeply analyzes the current situation of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market and the development prospects and opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global ICAD (Intracranial Atherosclerotic Disease) Pathology market in Chapter 13.

    By Player:

    • Acandis

    • Balt

    • TERUMO

    • Stryker

    • MicroPort

    By Type:

    • Stent

    • PTA Balloon

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 ICAD (Intracranial Atherosclerotic Disease) Pathology Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Outlook to 2022

    • 7.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.5 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    • 7.7 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption (2017-2022)

    8 Region and Country-wise ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Outlook to 2028

    • 8.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.5 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    • 8.7 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2022-2028)

    9 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook by Types and Applications to 2022

    • 9.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Stent Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global PTA Balloon Consumption and Growth Rate (2017-2022)

    • 9.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook by Types and Applications to 2028

    • 10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Stent Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global PTA Balloon Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Import and Export Analysis (Top 5 Countries)

    • 11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Analysis

    • 14.1 Acandis

      • 14.1.1 Acandis Company Details

      • 14.1.2 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • 14.2 Balt

      • 14.2.1 Balt Company Details

      • 14.2.2 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • 14.3 TERUMO

      • 14.3.1 TERUMO Company Details

      • 14.3.2 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • 14.4 Stryker

      • 14.4.1 Stryker Company Details

      • 14.4.2 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • 14.5 MicroPort

      • 14.5.1 MicroPort Company Details

      • 14.5.2 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of ICAD (Intracranial Atherosclerotic Disease) Pathology

    • Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Picture

    • Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Country (2017-2022)

    • Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Figure South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption and Growth Rate (2017-2022)

    • Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Country (2022-2028)

    • Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stent Consumption and Growth Rate (2017-2022)

    • Figure Global PTA Balloon Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PTA Balloon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Import by Region (Top 5 Countries) (2017-2028)

    • Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Export by Region (Top 5 Countries) (2017-2028)

    • Table Acandis (Foundation Year, Company Profile and etc.)

    • Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • Table Balt (Foundation Year, Company Profile and etc.)

    • Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • Table TERUMO (Foundation Year, Company Profile and etc.)

    • Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

    • Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • Table Stryker (Foundation Year, Company Profile and etc.)

    • Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service

    • Table MicroPort (Foundation Year, Company Profile and etc.)

    • Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US